SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001047469-10-008225
Filing Date
2010-09-22
Accepted
2010-09-22 17:15:26
Documents
3

Document Format Files

Seq Description Document Type Size
1 424(B)(3) a2200253z424b3.htm 424B3 5399316
2 G901837.JPG g901837.jpg GRAPHIC 18122
3 G37243.JPG g37243.jpg GRAPHIC 21759
  Complete submission text file 0001047469-10-008225.txt   5456467
Mailing Address 500 KENDALL STREET CAMBRIDGE MA 02142
Business Address 500 KENDALL STREET CAMBRIDGE MA 02142 6172527500
GENZYME CORP (Filer) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-169257 | Film No.: 101085150
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 500 KENDALL STREET CAMBRIDGE MA 02142
Business Address 500 KENDALL STREET CAMBRIDGE MA 02142 617-252-7500
Genzyme Therapeutic Products Limited Partnership (Filer) CIK: 0001495465 (see all company filings)

IRS No.: 010852078 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-169257-01 | Film No.: 101085151